Findings provide some of the strongest human evidence to date that expansion of the Huntington mutation is a key factor in ...

Process understanding also extends beyond regulatory compliance. Greater visibility into process performance can improve ...

Streptococcus pneumoniae is a member of the respiratory microbiome and can be found in almost 20 percent of adults globally. While many adults and children carry the bacteria without symptoms, the ...

While these use cases hold promise, many biopharma manufacturers have yet to advance them beyond proof of concept. The ...

Del-desiran was one of three clinical setbacks for Novartis within a week. On 4, Novartis and Ionis Pharmaceuticals ...

New detergent-based approaches aim to maintain viral clearance while addressing regulatory and environmental challenges.

GEN is publishing this CDMO Roundup to give our readers insights on what CDMOs themselves say potential clients should ...

Combining physics and generative AI creates novel, exquisitely active and selective molecules quickly and accurately, ...

A majority of biopharmas are expected to increase their reliance on CDMOs in coming years despite rising costs for their ...

The funds will support efforts to advance its lead candidate into human clinical trials in 2027, and expand its pipeline of ...

HiCB was developed to reduce cost of goods, lower capital investment, and enable agile production, according to Transcenta ...

Advances in membrane design are helping manufacturers address the demands of intensified bioprocessing and emerging ...